Prestige Consumer Healthcare
PBH
#3941
Rank
NZ$5.30 B
Marketcap
NZ$110.39
Share price
-0.78%
Change (1 day)
-25.72%
Change (1 year)

Prestige Consumer Healthcare (PBH) - Cash on Hand

Cash on Hand as of December 2025 : NZ$0.10 Billion

According to Prestige Consumer Healthcare's latest financial reports the company has NZ$0.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Prestige Consumer Healthcare - Cash on Hand chart (from 2004 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31NZ$0.17 B122.39%
2024-03-31NZ$77.62 M-16.88%
2023-03-31NZ$93.39 M138.21%
2022-03-31NZ$39.2 M-15.24%
2021-03-31NZ$46.25 M-70.95%
2020-03-31NZ$0.15 B294.68%
2019-03-31NZ$40.34 M-10.31%
2018-03-31NZ$44.98 M-24.63%
2017-03-31NZ$59.67 M51.68%
2016-03-31NZ$39.34 M37.41%
2015-03-31NZ$28.63 M-12.31%
2014-03-31NZ$32.65 M74.54%
2013-03-31NZ$18.7 M-19.24%
2012-03-31NZ$23.16 M32.15%
2011-03-31NZ$17.52 M-69.81%
2010-03-31NZ$58.06 M-6.42%
2009-03-31NZ$62.04 M720.73%
2008-03-31NZ$7.56 M-60.68%
2007-03-31NZ$19.22 M41.91%
2006-03-31NZ$13.54 M80.7%
2005-03-31NZ$7.49 M47.51%
2004-03-31NZ$5.08 M-20.27%
2003-03-31NZ$6.37 M-64.36%
2002-03-31NZ$17.88 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$33.48 B 32,128.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$18.03 B 17,255.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$19.21 B 18,390.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$24.96 B 23,923.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$12.88 B 12,297.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$0.37 B 263.94%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$17.65 B 16,891.33%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$7.40 B 7,025.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ$0.15 B 48.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$1.50 B 1,346.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel